Source: Public Filings
ENTITY
CStone Pharmaceuticals (2616 HK)
CStone Pharmaceuticals (2616 HK)
89
Analysis
Health Care • Hong Kong
CStone Pharmaceuticals operates as a biotechnology company. The Company develops immuno-oncology and molecularly targeted drugs to address unmet medical needs for cancer patients. CStone Pharmaceuticals serves customers worldwide.
more
x